User menu

Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.

Bibliographic reference Girardot, Michael ; Pecquet, Christian ; Chachoua, Ilyas ; Van Hees, Joanne ; Guibert, Sylvain ; et. al. Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.. In: Oncogene : including Oncogene Reviews, Vol. 34, no. 10, p. 1323-1332 (2015)
Permanent URL http://hdl.handle.net/2078.1/155932
  1. Constantinescu Stefan N., Girardot Michael, Pecquet Christian, Mining for JAK–STAT mutations in cancer, 10.1016/j.tibs.2007.12.002
  2. Yu Hua, Jove Richard, The STATs of cancer — new molecular targets come of age, 10.1038/nrc1275
  3. BAXTER E, SCOTT L, CAMPBELL P, EAST C, FOUROUCLAS N, SWANTON S, VASSILIOU G, BENCH A, BOYD E, CURTIN N, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, 10.1016/s0140-6736(05)74230-6
  4. James Chloé, Ugo Valérie, Le Couédic Jean-Pierre, Staerk Judith, Delhommeau François, Lacout Catherine, Garçon Loïc, Raslova Hana, Berger Roland, Bennaceur-Griscelli Annelise, Villeval Jean Luc, Constantinescu Stefan N., Casadevall Nicole, Vainchenker William, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, 10.1038/nature03546
  5. Kralovics Robert, Passamonti Francesco, Buser Andreas S., Teo Soon-Siong, Tiedt Ralph, Passweg Jakob R., Tichelli Andre, Cazzola Mario, Skoda Radek C., A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders, 10.1056/nejmoa051113
  6. Levine Ross L., Wadleigh Martha, Cools Jan, Ebert Benjamin L., Wernig Gerlinde, Huntly Brian J.P., Boggon Titus J., Wlodarska Iwona, Clark Jennifer J., Moore Sandra, Adelsperger Jennifer, Koo Sumin, Lee Jeffrey C., Gabriel Stacey, Mercher Thomas, D’Andrea Alan, Fröhling Stefan, Döhner Konstanze, Marynen Peter, Vandenberghe Peter, Mesa Ruben A., Tefferi Ayalew, Griffin James D., Eck Michael J., Sellers William R., Meyerson Matthew, Golub Todd R., Lee Stephanie J., Gilliland D. Gary, Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, 10.1016/j.ccr.2005.03.023
  7. Walz C., Ahmed W., Lazarides K., Betancur M., Patel N., Hennighausen L., Zaleskas V. M., Van Etten R. A., Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2V617F in mice, 10.1182/blood-2011-12-397554
  8. Yan D., Hutchison R. E., Mohi G., Critical requirement for Stat5 in a mouse model of polycythemia vera, 10.1182/blood-2011-03-345215
  9. Moucadel Virginie, Constantinescu Stefan N., Differential STAT5 Signaling by Ligand-dependent and Constitutively Active Cytokine Receptors, 10.1074/jbc.m407326200
  10. Nelson Erik A., Walker Sarah R., Alvarez James V., Frank David A., Isolation of Unique STAT5 Targets by Chromatin Immunoprecipitation-based Gene Identification, 10.1074/jbc.m408464200
  11. Casetti L., Martin-Lanneree S., Najjar I., Plo I., Auge S., Roy L., Chomel J.-C., Lauret E., Turhan A. G., Dusanter-Fourt I., Differential Contributions of STAT5A and STAT5B to Stress Protection and Tyrosine Kinase Inhibitor Resistance of Chronic Myeloid Leukemia Stem/Progenitor Cells, 10.1158/0008-5472.can-12-3955
  12. Girardot M., Pecquet C., Boukour S., Knoops L., Ferrant A., Vainchenker W., Giraudier S., Constantinescu S. N., miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets, 10.1182/blood-2008-06-165985
  13. Kato S., Han S.-Y., Liu W., Otsuka K., Shibata H., Kanamaru R., Ishioka C., Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis, 10.1073/pnas.1431692100
  14. Rajala H. L. M., Eldfors S., Kuusanmaki H., van Adrichem A. J., Olson T., Lagstrom S., Andersson E. I., Jerez A., Clemente M. J., Yan Y., Zhang D., Awwad A., Ellonen P., Kallioniemi O., Wennerberg K., Porkka K., Maciejewski J. P., Loughran T. P., Heckman C., Mustjoki S., Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia, 10.1182/blood-2012-12-474577
  15. Moriggl R, Gouilleux-Gruart V, Jähne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F, Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype., 10.1128/mcb.16.10.5691
  16. Nakatake M, Monte-Mor B, Debili N, Casadevall N, Ribrag V, Solary E, Vainchenker W, Plo I, JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms, 10.1038/onc.2011.313
  17. Pecquet C., Diaconu C. C., Staerk J., Girardot M., Marty C., Royer Y., Defour J.-P., Dusa A., Besancenot R., Giraudier S., Villeval J.-L., Knoops L., Courtoy P. J., Vainchenker W., Constantinescu S. N., Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes, 10.1182/blood-2011-08-372524
  18. Stark George R., Darnell James E., The JAK-STAT Pathway at Twenty, 10.1016/j.immuni.2012.03.013
  19. Fritsche Michael, Mundt Maren, Merkle Christian, Jähne Ruth, Groner Bernd, p53 suppresses cytokine induced, Stat5 mediated activation of transcription, 10.1016/s0303-7207(98)00140-3
  20. Liu Fan, Zhao Xinyang, Perna Fabiana, Wang Lan, Koppikar Priya, Abdel-Wahab Omar, Harr Michael W., Levine Ross L., Xu Hao, Tefferi Ayalew, Deblasio Anthony, Hatlen Megan, Menendez Silvia, Nimer Stephen D., JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation, 10.1016/j.ccr.2010.12.020
  21. Dawson Mark A., Bannister Andrew J., Göttgens Berthold, Foster Samuel D., Bartke Till, Green Anthony R., Kouzarides Tony, JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin, 10.1038/nature08448
  22. Mouzaki Athanasia, Panagoulias Ioannis, Dervilli Zoe, Zolota Vassiliki, Spadidea Panagiota, Rodi Maria, Panitsas Fotios P., Lagadinou Eleni, de Lastic Anne-Lise, Georgakopoulos Tassos, Expression patterns of leptin receptor (OB-R) isoforms and direct in vitro effects of recombinant leptin on OB-R, leptin expression and cytokine secretion by human hematopoietic malignant cells, 10.1016/j.cyto.2009.07.006
  23. DeJong J., Bernstein R., Roeder R. G., Human general transcription factor TFIIA: characterization of a cDNA encoding the small subunit and requirement for basal and activated transcription., 10.1073/pnas.92.8.3313
  24. Higuti T., Tsurumi C., Kawamura Y., Tsujita H., Osaka F., Yoshihara Y., Tani I., Tanaka K., Ichihara A., Molecular cloning of cDNA for the import precursor of human coupling factor 6 of H+-ATP synthase in mitochondria, 10.1016/0006-291x(91)90178-a
  25. Lin Y., The death-promoting activity of p53 can be inhibited by distinct signaling pathways, 10.1182/blood-2002-02-0504
  26. Townsend Paul A., Scarabelli Tiziano M., Davidson Sean M., Knight Richard A., Latchman David S., Stephanou Anastasis, STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis, 10.1074/jbc.m302637200
  27. Chipoy C, Brounais B, Trichet V, Battaglia S, Berreur M, Oliver L, Juin P, Rédini F, Heymann D, Blanchard F, Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53, 10.1038/sj.onc.1210492
  28. Kramer OH, JAKSTAT, 1, 203 (2012)
  29. Klampfl Thorsten, Gisslinger Heinz, Harutyunyan Ashot S., Nivarthi Harini, Rumi Elisa, Milosevic Jelena D., Them Nicole C.C., Berg Tiina, Gisslinger Bettina, Pietra Daniela, Chen Doris, Vladimer Gregory I., Bagienski Klaudia, Milanesi Chiara, Casetti Ilaria Carola, Sant'Antonio Emanuela, Ferretti Virginia, Elena Chiara, Schischlik Fiorella, Cleary Ciara, Six Melanie, Schalling Martin, Schönegger Andreas, Bock Christoph, Malcovati Luca, Pascutto Cristiana, Superti-Furga Giulio, Cazzola Mario, Kralovics Robert, Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms, 10.1056/nejmoa1311347
  30. Nangalia J., Massie C.E., Baxter E.J., Nice F.L., Gundem G., Wedge D.C., Avezov E., Li J., Kollmann K., Kent D.G., Aziz A., Godfrey A.L., Hinton J., Martincorena I., Van Loo P., Jones A.V., Guglielmelli P., Tarpey P., Harding H.P., Fitzpatrick J.D., Goudie C.T., Ortmann C.A., Loughran S.J., Raine K., Jones D.R., Butler A.P., Teague J.W., O'Meara S., McLaren S., Bianchi M., Silber Y., Dimitropoulou D., Bloxham D., Mudie L., Maddison M., Robinson B., Keohane C., Maclean C., Hill K., Orchard K., Tauro S., Du M.-Q., Greaves M., Bowen D., Huntly B.J.P., Harrison C.N., Cross N.C.P., Ron D., Vannucchi A.M., Papaemmanuil E., Campbell P.J., Green A.R., Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2, 10.1056/nejmoa1312542
  31. Shi Song, Calhoun Healani C, Xia Fan, Li Jinghong, Le Long, Li Willis X, JAK signaling globally counteracts heterochromatic gene silencing, 10.1038/ng1860
  32. Baker S., Markowitz S, Fearon E., Willson J., Vogelstein B, Suppression of human colorectal carcinoma cell growth by wild-type p53, 10.1126/science.2144057
  33. Bommer Guido T., Gerin Isabelle, Feng Ying, Kaczorowski Andrew J., Kuick Rork, Love Robert E., Zhai Yali, Giordano Thomas J., Qin Zhaohui S., Moore Bethany B., MacDougald Ormond A., Cho Kathleen R., Fearon Eric R., p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes, 10.1016/j.cub.2007.06.068
  34. Wood Timothy J.J, Sliva Daniel, Lobie Peter E, Goullieux Fabrice, Mui Alice L, Groner Bernd, Norstedt Gunnar, Lars-Arne Haldosén, Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter, 10.1016/s0303-7207(97)00075-0
  35. Pearson Paul N., Palmer Martin R., 10.1038/35021000
  36. Borgel Julie, Guibert Sylvain, Li Yufeng, Chiba Hatsune, Schübeler Dirk, Sasaki Hiroyuki, Forné Thierry, Weber Michael, Targets and dynamics of promoter DNA methylation during early mouse development, 10.1038/ng.708
  37. Huang Da Wei, Sherman Brad T, Lempicki Richard A, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, 10.1038/nprot.2008.211